Emily Zeitler
@EmilyZeitler
Followers
399
Following
178
Media
28
Statuses
156
Cardiac Electrophysiologist. Outcomes investigator. Implanter. Extractor. Ablationist. Regulatory enthusiast.
Joined July 2011
#OriginalResearch: Left atrial appendage occlusion was associated with a lower risk of death, stroke and bleeding compared to anticoagulation among females and males @EmilyZeitler @JonHsuMD @AndreaRussoEP @drdevignair @djdardenMD @MCoylewright
https://t.co/nHaBaHJzwM
5
50
103
Contemporary Trends in Cardiac Electrophysiology Procedures in the United States, and Impact of a Global Pandemic, by @monte_scott, @ba_steinberg, and colleagues https://t.co/2xQo8v1Nhu
heartrhythmopen.com
There are limited data on trends in nationwide cardiac electrophysiology (EP) procedures in the United States before and during the global COVID-19 pandemic.
0
4
6
So much work to do but inspired by this work with @KateKiernanMD @LarryRJacksonII @ECGMD @shayne_dodge
Racial and ethnic differences in implantable cardioverter-defibrillator patient selection, management, and outcomes, by @EmilyZeitler and colleagues #HRO2GlobalVoices
https://t.co/L0gSgVhlv7
0
3
13
The best leadership and networking opportunity for #womeninEP Meet your professional soulmates @docAnneSquared @ciorsti @aartisdalal @cm_beach
Would you like to influence other #WomeninEP and push EP as a career choice to reduce gender disparities? Apply to HRS' Growth & Leadership Opportunity for Women in EP (#GLOWE) w/ Chair @AndreaRussoEP & VC @netta_doc. Applications are due by Feb. 3, 2023. https://t.co/HU52uNoBfm
0
2
2
Deeply feeling the absence of @laurenggilstrap now more than ever. Thank you @JCardFail for this remembrance. We all have so much to live up to. @DrMarkCreager
Thank you #LynneStevenson & #MarkCreager for helping us pay homage to #LaurenGilstrap and her legacy @JCardFail 🙏🏽 May we honor her memory - she was one of us. @robmentz
https://t.co/t8hbZ2uNzK
0
1
16
So much to learn about the neuro-cardiac connections in arrhythmia care! @TJaredBunch @AndreaRussoEP @ba_steinberg @JonPicciniSr Thanks to @BiosenseWebster for support !
Open Access: Comparative risk of dementia among patients with atrial fibrillation treated with catheter ablation versus anti-arrhythmic drugs. https://t.co/ejsGxfD6MR
#Cardiology #Afib @EmilyZeitler @AndreaRussoEP
2
4
13
Open Access: Comparative risk of dementia among patients with atrial fibrillation treated with catheter ablation versus anti-arrhythmic drugs. https://t.co/ejsGxfD6MR
#Cardiology #Afib @EmilyZeitler @AndreaRussoEP
1
5
7
Can't wait to meet you! You all look awfully smart... Must be #EPeeps in the making.
We are so excited to welcome our next class of #cv #fellows to @DHCVFellowship @DHHeartVascular . We can’t wait to meet everyone! @DrMarkCreager @CynthiaTaub @DadekianGreg @mnyoung1 @CapnIntrvention @DeVriesJt @stanhenkin
1
0
11
Wish I could take credit for this wisdom but it was passed on to me by the great @SanaAlkhatib9 !
@EmilyZeitler giving great advice at a @WomenAs1 conference this am: “Be a finisher. If you finish what you say yes to - you will be way ahead of the pack.” Incredibly insightful advice for #earlycareer #cardiotwitter
0
2
16
There are no words. No words that could do this brilliant, humane, adventurous, indefatigable human justice. We were so lucky to love her. My heart is broken. https://t.co/KLUmgtVgPq
We are profoundly saddened by the loss of Dr. Lauren Gilstrap on October 21st. Lauren was not only an incredibly talented physician, researcher, and teacher, but she was a dear friend to so many. She was a shining light and embodied true excellence in everything she did.
1
0
22
Now online @Heart_BMJ, our analysis of ~60,000 patients undergoing catheter ablation for #AFib showing ↑ risk of longer hospitalization stays, major/specific adverse events, and lower quality of life in women 🫀 @jfreeMD @EmilyZeitler @YaleCardiology
https://t.co/3UtzSmQHaS
heart.bmj.com
Objective Older, relatively small studies identified female sex as a risk factor for adverse events after catheter ablation for atrial fibrillation (AF). We aimed to assess contemporary sex-based...
1
4
16
Credit goes to @US_FDA @FDADeviceInfo for striving towards a regulatory paradigm that is unobtrusive to clinical care while allowing post market data collection to inform device design and regulatory decisions.
Hot off the press!!! #JICE A "Design/Rationale" paper describing the EP PASSION project for monitoring and developing real world data for CIEDs, CIED monitoring, and/or device-related complications.⬇️ https://t.co/Z2GspMZVh9
#Epeeps #CardioTwitter #MedTwitter
0
1
8
We have launched ‘Advocacy in Action’ w/ @HRSonline President-Elect Jodie Hurwitz, MD, FHRS. In the first episode @jhurwitz55 sits w/ HRS Health Policy Chair, Christopher Liu, MD, FHRS to discuss 2023 @CMSGov proposed #reimbursement cuts. Full 🎥 here > https://t.co/wLst3BRrTL
0
9
18
These changes are having a tremendous and possibly underappreciated impact on the device development ecosystem. Work from the #3DSymposium.
Pleased to see our manuscript in JSCAI on how the new EU Regulations (MDD to MDR) are upending med device evaluation and commercialization @dhh, @EmilyZeitler, @MyJSCAI
https://t.co/KbkqMDbgOi
0
1
3
And now I'm wondering if this was intentional to appeal to my impulse to help those in true editorial need... Well played, predatory journal, well played.
1
0
4
Couldn't agree more, @AndreaRussoEP ! What a fabulous program. This is @HRSonline delivering true mentorship and advocacy. Can't wait for the #GLOWE 2023 reunion.
Congratulations to the graduating GLOWE class and welcome to the class of 2023! Thanks to the leadership of @jenniferavari and Riki Green, hard work of Moriah Vincent, and support of @pavblake and @HRSonline leadership Fred Kusumoto, @AndrewKrahnMD @jhurwitz55 @EP_mom1
0
0
6
It's that time of year to #GoRedNH. Today and every day. Also, we have the BEST #WIC @DHHeartVascular . @laurenggilstrap @CynthiaTaub
1
3
22
Just in time to inform important and pressing coverage policy discussions related to emerging technologies. @laurenggilstrap @SanaAlkhatib9 @JonSkinner17 @MCoylewright Coverage With Evidence Development: Where Are We Now? https://t.co/ytfJYE0Ji4 via @AJMC_Journal
ajmc.com
Review of CMS’ coverage with evidence development program exposes a need to improve program transparency and clarify requirements and timetables for reporting to improve access to novel therapies.
0
2
7
Are you an early career EP? Want to learn new skills, expand your network & increase your visibility with industry partners? @WomenAs1 wants to help #EPeeps Apply to the 2022 CLIMB Cardiac EP program now! This is your #TIMETOCLIMB. @HRSonline
1
10
16